RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5538
Malaria parasiteP. yoelii
Genotype
TaggedGene model (rodent): PY17X_0907300; Gene model (P.falciparum): PF3D7_1143100; Gene product: AP2 domain transcription factor AP2-O, putative (ApiAP2; AP2-O)
Name tag: GFPmut2
Phenotype Fertilization and ookinete;
Last modified: 9 January 2025, 13:57
  *RMgm-5538
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 39777415
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. yoelii
Parent strain/lineP. y. yoelii 17XNL
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherRios KT, Lindner SE
Name Group/DepartmentDepartment of Biochemistry and Molecular Biology
Name InstitutePennsylvania State University
CityUniversity Park
CountryUS
Name of the mutant parasite
RMgm numberRMgm-5538
Principal namePyApiAP2-O::GFP
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot tested
Gametocyte/GameteNot tested
Fertilization and ookineteZygotes were enriched of parasites expressing PyApiAP2-O::GFP in combination with staining with a zygote-specific antibody, anti-Pys25
OocystNot tested
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a C-terminal GFP-tagged version of AP2-O

Protein (function)
Most sequence-specific transcription factor families found in other eukaryotes seem to be absent from Plasmodium. Instead, an expansion of a protein family containing one or more apetala2 (AP2) DNA-binding domains was observed across the phylum apicomplexa. In total, 27 members of this family have been found in the human malaria parasite Plasmodium falciparum (although a possible 28th member of the family may be present. In total, 26 of these have syntenic orthologs in rodent malaria species, each with its unique stage-specific expression profile. AP2-O plays a role in ookinete formation. Parasites lacking expression of AP2-O show the following phenotypes: 'Normal gametocyte production and gamete formation. Evidence for normal fertilisation. Formation of retort shaped, immature ookinetes but no mature ookinete production'.

Phenotype
Zygotes were enriched of parasites expressing PyApiAP2-O::GFP in combination with staining with a zygote-specific antibody, anti-Pys25.

Evidence in the paper is presented that: 'the compositional and spatial rearrangements detected by proximity proteomics are consistent with DOZI/CITH/ALBA mRNPs 1) adopting a condensed state during translational repression in female gametocytes, and then 2) undergoing composition changes that promote its elongation in zygotes following the release from translational repression'.

Additional information

Other mutants


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PY17X_0907300
Gene Model P. falciparum ortholog PF3D7_1143100
Gene productAP2 domain transcription factor AP2-O, putative
Gene product: Alternative nameApiAP2; AP2-O
Details of the genetic modification
Name of the tagGFPmut2
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationGeneration and Validation of Transgenic Parasite Lines: Transgenic Plasmodium yoelii (17XNL strain) parasite lines were created using conventional reverse genetics approaches with specific targeting regions for double homologous recombination for each tagged line. Targeting regions for the coding sequence (CDS) and 3’ UTR of target genes were PCR amplified from wild-type Py17XNL genomic DNA and combined into a single amplicon by sequence overlap extension (SOE) PCR. This amplicon was inserted into an intermediate plasmid (pCR-Blunt) for initial sequence verification of the target regions. The targeting regions were then inserted into a final pDEF plasmid vector containing the coding sequence for GFPmut2, or TurboID and GFPmut2, with the P. berghei DHFR 3’ UTR, and the human DHFR drug resistance cassette. The final plasmids were linearized and transfected into Accudenz-purified P. yoelii schizonts produced in ex vivo cultures.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6